PUBLICATIONS

A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine

Yu HJ, Thijssen E, van Brummelen E, et al.

2022 Apr 15; doi:10.1002/mds.29016

Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut.

Nimmo JT, Smith H, Wang CY, Teeling JL, Nicoll JAR, Verma A, Dodart JC, Liu Z, Lin F, Carare RO

2022 Jan;143(1):55-73. doi: 10.1007/s00401-021-02381-5

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.

Nimmo JT, Verma A, Dodart JC, Wang CY, Savistchenko J, Melki R, Carare RO, Nicoll JAR

2020 Nov 30;12(1):159. doi: 10.1186/s13195-020-00727-x

High neutralizing antibody levels against SARS-CoV-2 Omicron after UB-612 booster vaccination

Farshad Guirakhoo, Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, Wen-Jiun Peng, Hope Liu, Lixia Wang, Marina Johnson, Adam Hunt, Mei Mei Hu, Thomas P Monath, Alexander Rumyantsev, David Goldblatt

2022 Mar 21; doi.org/10.1101/2022.03.18.484436

Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine

Chang Yi wang, Kao-Pin Hwang, Hui-Kai Kuo, James Peng, Daphne Shen, Besheng Kuo, Kuo-Liang Hou, Jennifer Cheng, Min-Sheng Wang, Ya-Ting Yang, Juin-Hua Huang, Han Chen Chiu, Ming-Han Jiang, Hao-Yu Shih, Hsuan-Yu Shen, Po-Yen Chang, Yu-Rou Lan, Sky Chen, Hope Liu, Yu-Hsin Ho, Feng Lin, Shuang Ding, Zhi Liu, Huang-Ting Wu, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, Yu-Chi Chou, Mary Kate Morris, Carl Hanson, Farshad Guirakhoo, Michael Hellerstein, Mei Mei Hu, Hui-Jiing Yu, Chwan-Chuen King King, Donald Heppner, Tracy Kemp, Tom Monath

2021 Oct 18; DOI: 10.21203/rs.3.rs-944205/v1

A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an Adeno Associated Virus Human Angiotensin-Converting Enzyme 2 (AAV hACE2) Mouse Model

Farshad Guirakhoo, Lucy Kuo, James Peng, Juin Hua Huang, Ben Kuo, Feng Lin, Kevin Liu, Zhi Liu, Grace Wu, Shuang Ding, Lou-Liang Hou, Jennifer Cheng, Vicky Yang, Hank Jiang, Jason Wang, Tony Chen, WeiGuo Xia, Ed Lin, Chung Ho Hung, Kate Chen, Zhonghao Shih, Yilin Lin, Brandon T. Schurter, Mei Mei Hu, Gray Heppner, Delphine C. Malherbe, Alexander Bukreyev, Michael Hellerstein, Thomas Monath, Chang Yi Wang

2020 Nov 30; doi.org/10.1101/2020.11.30.399154

UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease.

Chang Yi Wang, Pei-Ning Wang, Ming-Jang Chiu,Connie L. Finstad, Feng Lin, Shugene Lynn, Yuan-Hung Tai, Xin De Fang,a Kesheng Zhao, Chung-Ho Hung, Yiting Tseng, Wen-Jiun Peng, Jason Wang, Chih-Chieh Yu, Be-Sheng Kuo, and Paul A. Frohnac

2017 Jun; 3(2): 262–272. doi: 10.1016/j.trci.2017.03.005

Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.

Chang Yi Wang, Connie L Finstad, Alan M Walfield, Charles Sia, Kenneth K Sokoll, Tseng-Yuan Chang, Xin De Fang, Chung Ho Hung, Birgit Hutter-Paier, Manfred Windisch

2007 Apr 20;25(16):3041-52. doi: 10.1016/j.vaccine.2007.01.031. Epub 2007 Jan 19

Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications

Chang Yi Wang , Alan M Walfield

2005 Mar 18;23(17-18):2049-56. doi: 10.1016/j.vaccine.2005.01.007.